NGNE Similar Chart Price Prediction
The price of NGNE is predicted to go up -0.4%, based on the high correlation periods with LAZR. The similarity of these two price pattern on the periods is 94.38%.
NGNE
LAZR
Down: -0.4%Similarity: 94.38%
NGNE Revenue Forecast
NGNE EPS Forecast
NGNE FAQs
What is bull’s view on NGNE?
What is bear's view on NGNE?
NGNE Analyst's Forecast
Keith Tapper
BMO Capital
Buy
2024-11-20
Price Target
$60 → $45
Upside
+193.54%
BMO Capital lowered the firm's price target on Neurogene to $45 from $60 and keeps an Outperform rating on the shares. The shares are "priced for failure when the longer-term story remains intact" that NGN-401 remains competitive at low-dose, says the analyst, who lowered the firm's price target to reflect challenges to the narrative given recent updates and headline risk.
Keith Tapper
BMO Capital
Buy
2024-11-12
Price Target
$65 → $60
Upside
+202.72%
Joel Beatty
Baird
Buy
2024-11-12
Price Target
$54 → $72
Upside
+263.27%
